Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Berg

Showing results (221-230 of 631) with videos related to

Pageof 64
Sort By:
Genes|March 29, 2023
Association between Variants in the <i>OCA2-HERC2</i> Region and Blue Eye Colour in <i>HERC2</i> rs12913832 AA and AG IndividualsNina Mjølsnes Salvo, Jeppe Dyrberg Andersen, Kirstin Janssen, et al.
Hepatology (Baltimore, Md.)|February 26, 2003
Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapyThomas Berg, Christoph Sarrazin, Eva Herrmann, et al.
BMJ Open|November 24, 2021
Multimorbidity, psychoactive substance use and psychological distress among acute medically ill patients: a cross-sectional studySaranda Kabashi, Danil Gamboa, Vigdis Vindenes, et al.
European Journal of Gastroenterology & Hepatology|August 11, 2016
Detection of molecular bacterascites in decompensated cirrhosis defines a risk with decreased survivalCornelius Engelmann, Sandra Krohn, Delia Prywerek, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2021
Glecaprevir/pibrentasvir for 8 weeks in patients with compensated cirrhosis: Safety and effectiveness data from the German Hepatitis C-RegistryHartwig Klinker, Uwe Naumann, Martin Rössle, et al.
Visceral Medicine|October 23, 2018
Acute-on-Chronic Liver FailureChristian M Lange, Wolf Otto Bechstein, Thomas Berg, et al.
Journal of Hepatology|November 3, 2004
Fibrosis progression after liver transplantation in patients with recurrent hepatitis CUlf P Neumann, Thomas Berg, Marcus Bahra, et al.
Annals of Transplantation|February 23, 2008
Peginterferon alfa-2b plus ribavirin for the treatment of hepatitis C recurrence following combined liver and kidney transplantationVolker Schmitz, Anja Kiessling, Marcus Bahra, et al.
Glycobiology|August 8, 2007
Characterization and subcellular localization of human neutral class II alpha-mannosidase [corrected]Elina Kuokkanen, Wesley Smith, Marika Mäkinen, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 18, 2020
Safety and efficacy of direct oral anticoagulants under long-term immunosuppressive therapy after liver, kidney and pancreas transplantationChristian Pfrepper, Adam Herber, Antje Weimann, et al.
Pageof 64

Showing results (221-230 of 631) with videos related to

Sort By:
Pageof 64
Genes|March 29, 2023
Association between Variants in the <i>OCA2-HERC2</i> Region and Blue Eye Colour in <i>HERC2</i> rs12913832 AA and AG IndividualsNina Mjølsnes Salvo, Jeppe Dyrberg Andersen, Kirstin Janssen, et al.
Hepatology (Baltimore, Md.)|February 26, 2003
Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapyThomas Berg, Christoph Sarrazin, Eva Herrmann, et al.
BMJ Open|November 24, 2021
Multimorbidity, psychoactive substance use and psychological distress among acute medically ill patients: a cross-sectional studySaranda Kabashi, Danil Gamboa, Vigdis Vindenes, et al.
European Journal of Gastroenterology & Hepatology|August 11, 2016
Detection of molecular bacterascites in decompensated cirrhosis defines a risk with decreased survivalCornelius Engelmann, Sandra Krohn, Delia Prywerek, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2021
Glecaprevir/pibrentasvir for 8 weeks in patients with compensated cirrhosis: Safety and effectiveness data from the German Hepatitis C-RegistryHartwig Klinker, Uwe Naumann, Martin Rössle, et al.
Visceral Medicine|October 23, 2018
Acute-on-Chronic Liver FailureChristian M Lange, Wolf Otto Bechstein, Thomas Berg, et al.
Journal of Hepatology|November 3, 2004
Fibrosis progression after liver transplantation in patients with recurrent hepatitis CUlf P Neumann, Thomas Berg, Marcus Bahra, et al.
Annals of Transplantation|February 23, 2008
Peginterferon alfa-2b plus ribavirin for the treatment of hepatitis C recurrence following combined liver and kidney transplantationVolker Schmitz, Anja Kiessling, Marcus Bahra, et al.
Glycobiology|August 8, 2007
Characterization and subcellular localization of human neutral class II alpha-mannosidase [corrected]Elina Kuokkanen, Wesley Smith, Marika Mäkinen, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 18, 2020
Safety and efficacy of direct oral anticoagulants under long-term immunosuppressive therapy after liver, kidney and pancreas transplantationChristian Pfrepper, Adam Herber, Antje Weimann, et al.
Pageof 64